Biolidics Ltd. released its earnings results on Nov 01, 2024. The company reported -S$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.001.

Q: Is Biolidics Ltd. overvalued?

According to Wall Street analysts Biolidics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Biolidics Ltd. have?

Biolidics Ltd. has 1,690,758,800 shares outstanding.

Q: What happened to Biolidics Ltd.’s price movement after its last earnings report?

Biolidics Ltd. reported an EPS of -S$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Compare

1 Followers

8YY Stock Chart & Stats

Day’s Range― - ―

52-Week Range<S$0.01 - S$0.03

Previous CloseN/A

Volume13.75M

Average Volume (3M)5.84M

Market Cap

S$45.65M

Enterprise ValueS$8.97M

Total Cash (Recent Filing)2.45M

Total Debt (Recent Filing)6.32M

Price to Earnings (P/E)―

Beta0.45

Next Earnings

Feb 26, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,690,758,800

10 Day Avg. Volume4,548,110

30 Day Avg. Volume5,843,257

Standard DeviationN/A

R-SquaredN/A

AlphaN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

---

Biolidics Ltd. News

PremiumCompany Announcements

Biolidics Completes Acquisition to Expand E-Sports Presence

4M ago

8YY

PremiumCompany Announcements

Biolidics Ltd. Approves Key Share Issuance and Transfer

4M ago

8YY

PremiumCompany Announcements

Biolidics Ltd. Completes Major Share Issuance

5M ago

8YY

PremiumCompany Announcements

Biolidics Ltd Announces New Share Listings

5M ago

8YY

PremiumCompany Announcements

Biolidics Ltd Amends Subscription Agreement Terms

6M ago

8YY

PremiumCompany Announcements

Biolidics Ltd Announces Major Acquisition and Funding

7M ago

8YY

PremiumCompany Announcements

Biolidics Ltd Announces Key Leadership Changes

8M ago

8YY

PremiumCompany Announcements

Biolidics Limited Subsidiary Faces Liquidation

8M ago

8YY

See All SG:8YY News

---

Financials

Quarterly

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

29.90% Insiders

― Mutual Funds

― Other Institutional Investors

70.10% Public Companies and

Individual Investors

Detailed Ownership Overview >

8YY FAQ

What was Biolidics Ltd.’s price range in the past 12 months?

Biolidics Ltd. lowest share price was <S$0.01 and its highest was S$0.03 in the past 12 months.

What is Biolidics Ltd.’s market cap?

Biolidics Ltd.’s market cap is S$45.65M.

When is Biolidics Ltd.’s upcoming earnings report date?

Biolidics Ltd.’s upcoming earnings report date is Feb 26, 2025 which is in 9 days.

How were Biolidics Ltd.’s earnings last quarter?

Biolidics Ltd. released its earnings results on Nov 01, 2024. The company reported -S$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.001.

Is Biolidics Ltd. overvalued?

According to Wall Street analysts Biolidics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Biolidics Ltd. pay dividends?

Biolidics Ltd. does not currently pay dividends.

What is Biolidics Ltd.’s EPS estimate?

Biolidics Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Biolidics Ltd. have?

Biolidics Ltd. has 1,690,758,800 shares outstanding.

What happened to Biolidics Ltd.’s price movement after its last earnings report?

Biolidics Ltd. reported an EPS of -S$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Biolidics Ltd.?

Currently, no hedge funds are holding shares in SG:8YY

---

Biolidics Ltd. Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

-80.51%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Biolidics Ltd.

Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and medical science and electronics related industrial design services and investment holding. Its segments include Cancer; Infectious diseases; Laboratory services; and Corporate segment. It derives major revenue from The infectious diseases segment that involves the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the infectious diseases field. Its operations are spread across Singapore, Japan, China, Europe, United States, Hong Kong, Philippines, Indonesia, and Others.

---